JPS584019B2 - フクソカンシキカゴウブツノ ホウコウゾクアミドノセイホウ - Google Patents

フクソカンシキカゴウブツノ ホウコウゾクアミドノセイホウ

Info

Publication number
JPS584019B2
JPS584019B2 JP7534871A JP3487175A JPS584019B2 JP S584019 B2 JPS584019 B2 JP S584019B2 JP 7534871 A JP7534871 A JP 7534871A JP 3487175 A JP3487175 A JP 3487175A JP S584019 B2 JPS584019 B2 JP S584019B2
Authority
JP
Japan
Prior art keywords
methoxy
benzyl
piperidyl
amino
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP7534871A
Other languages
English (en)
Japanese (ja)
Other versions
JPS50129573A (es
Inventor
アルマンド・ベガ・ノベローラ
エル・ジー・ダブリユ・スピケツト
ホセ・プリエント・ソト
ヤシント・モラグエス・モーリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANFUAA SA
Original Assignee
ANFUAA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB12572/74A external-priority patent/GB1507462A/en
Application filed by ANFUAA SA filed Critical ANFUAA SA
Publication of JPS50129573A publication Critical patent/JPS50129573A/ja
Publication of JPS584019B2 publication Critical patent/JPS584019B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP7534871A 1974-03-21 1975-03-22 フクソカンシキカゴウブツノ ホウコウゾクアミドノセイホウ Expired JPS584019B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12572/74A GB1507462A (en) 1974-03-21 1974-03-21 N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB3540274 1974-08-12

Publications (2)

Publication Number Publication Date
JPS50129573A JPS50129573A (es) 1975-10-13
JPS584019B2 true JPS584019B2 (ja) 1983-01-24

Family

ID=26249107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7534871A Expired JPS584019B2 (ja) 1974-03-21 1975-03-22 フクソカンシキカゴウブツノ ホウコウゾクアミドノセイホウ

Country Status (11)

Country Link
JP (1) JPS584019B2 (es)
AR (1) AR216043A1 (es)
CH (1) CH602641A5 (es)
DK (1) DK147854C (es)
ES (5) ES435755A1 (es)
FI (1) FI60200C (es)
FR (1) FR2264530A1 (es)
KE (1) KE2900A (es)
NL (1) NL159660B (es)
NO (1) NO144108C (es)
SE (1) SE427750B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
FR2446274A1 (fr) * 1979-01-15 1980-08-08 Delalande Sa Nouveaux derives de salicylamide, leur procede de preparation et leur application en therapeutique
EP0343307A1 (en) * 1988-05-26 1989-11-29 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. 4-Piperidinealkanamine derivatives
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
FR2766484B1 (fr) * 1997-07-25 1999-09-17 Logeais Labor Jacques Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
FR2766486B1 (fr) * 1997-07-25 1999-09-17 Logeais Labor Jacques Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse
KR100962732B1 (ko) * 2005-06-02 2010-06-09 에프. 호프만-라 로슈 아게 피페리딘-4-일-아마이드 유도체 및 ｓｓｔ 수용체 아형 5길항제로서 그의 용도
KR100976063B1 (ko) * 2007-03-16 2010-08-17 동아제약주식회사 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
HUE039164T2 (hu) 2011-11-29 2018-12-28 Vivozon Inc Új benzamid-származékok és alkalmazásuk

Also Published As

Publication number Publication date
FR2264530B1 (es) 1978-11-10
FI750825A (es) 1975-09-22
ES435755A1 (es) 1977-04-01
ES435754A1 (es) 1977-04-01
NL159660B (nl) 1979-03-15
SE427750B (sv) 1983-05-02
KE2900A (en) 1978-12-01
DK117675A (es) 1975-09-22
ES435753A1 (es) 1977-04-01
NO750957L (es) 1975-09-23
JPS50129573A (es) 1975-10-13
FR2264530A1 (en) 1975-10-17
NO144108B (no) 1981-03-16
FI60200B (fi) 1981-08-31
NO144108C (no) 1981-06-24
ES435757A1 (es) 1977-04-01
AR216043A1 (es) 1979-11-30
SE7503196L (es) 1975-09-22
DK147854C (da) 1985-07-22
NL7503417A (nl) 1975-09-23
ES435756A1 (es) 1977-04-01
CH602641A5 (es) 1978-07-31
FI60200C (fi) 1981-12-10
DK147854B (da) 1984-12-24

Similar Documents

Publication Publication Date Title
US4138492A (en) Aromatic amides of heterocyclic compounds and therapeutic compositions containing same
US4943578A (en) Piperazine compounds
KR100263414B1 (ko) 티에노 [3,2-b] 피리딘 유도체
US3654287A (en) Spiroindanylpiperidines
US5070087A (en) Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
AU2001275326B2 (en) Treatment of gastroesophageal reflux disease using piperidine derivatives
US4929621A (en) 1-1[(2-pyrimidinyl)amino-alkyl]piperidines, their preparation and their application in therapy
GB1586468A (en) Piperidine derivatives
JPH02243688A (ja) 新規キヌクリジン類、該化合物を含有する医薬組成物、及びその製造方法
WO1990014347A1 (en) Indole derivatives and medicine
JPH11503143A (ja) ５ｈｔ▲下１ｄ▼ アンタゴニストとしてのビフェニルアミド誘導体
US5026858A (en) Piperidine derivative
AU2001275326A1 (en) Treatment of gastroesophageal reflux disease using piperidine derivatives
JPS6348272B2 (es)
JPH02138254A (ja) 複素環誘導体
IE44639B1 (en) Oxadiazoloyl-substituted compounds having pharmacological activity
WO1992004347A1 (fr) Derive d'indole et medicament
JPS584019B2 (ja) フクソカンシキカゴウブツノ ホウコウゾクアミドノセイホウ
AU5292393A (en) Tocolytic oxytocin receptor antagonists
US3091568A (en) Therapeutic phthalimidines for relieving cough and producing anesthesia
US4021552A (en) 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES
JPH04266873A (ja) ピペリジン誘導体
US4424226A (en) Pyridobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof
WO2001002386A1 (en) SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONISTS HAVING 5H-DIBENZ[b,f]AZEPINE STRUCTURE
EP0501997B1 (en) N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals